Markets » Mutual Funds » Asset Allocation

Reliance Pharma Fund - Direct (Bonus) - Scheme Profile

Fund

Fund House : Reliance Mutual Fund

Fund Class : Equity - Pharma

NAV 23 Mar 2017 140.57 1.62
(1.17%)

Asset Type

Asset Allocation
CBLO 0.59
Equity 97.66
Net CA & Others 1.75
Equity Sector No. of Shares Mkt Value % of Assets Stocks Return
Asset / Company Name     (Rs cr)   Last 3 Mths
Cadila Health. Pharmaceuticals - Indian - Bulk Drugs & Fo... 3,300,000 145.28 9.77 32.09
Aurobindo Pharma Pharmaceuticals - Indian - Bulk Drugs & Fo... 2,050,000 138.83 9.34 6.18
Abbott India Pharmaceuticals - Multinational 300,587 134.15 9.02 0.04
Sun Pharma.Inds. Pharmaceuticals - Indian - Bulk Drugs & Fo... 1,900,350 129.03 8.68 12.74
Divi's Lab. Pharmaceuticals - Indian - Bulk Drugs 1,556,014 118.08 7.94 -28.06
Sanofi India Pharmaceuticals - Multinational 274,423 113.11 7.61 9.79
› More

Sector Allocation

You can check out the sectoral allocation of the investments made for that scheme by the mutual fund in this Piechart as on the date selected.

Sector Name
Finance & Investments 4.09
Healthcare 4.54
Miscellaneous 6.11
NA 2.34
Pharmaceuticals - Indian - Bulk Drugs 14.88
Pharmaceuticals - Indian - Bulk Drugs & Formln 51.41
Pharmaceuticals - Multinational 16.63

Top Holdings

You can check out the Top Holdings of the investments made for that scheme by the mutual fund in
this Piechart as on the date selected.

Company Name
Abbott India 9.02
Aurobindo Pharma 9.34
Cadila Health. 9.77
Cipla 6.67
Divi's Lab. 7.94
Dr Reddy's Labs 6.82
Glenmark Pharma. 4.98
Health.Global 3.97